메뉴 건너뛰기




Volumn 101, Issue 3, 2000, Pages 264-269

Association of blood pressure with fibrinolytic potential in the Framingham Offspring population

Author keywords

Cardiovascular diseases; Fibrinolysis; Hypertension

Indexed keywords

BLOOD CLOTTING FACTOR 7; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

EID: 0034711728     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.3.264     Document Type: Article
Times cited : (168)

References (49)
  • 1
    • 0002859079 scopus 로고
    • Hypertension in Framingham
    • Paul O, ed. New York, NY: Thieme Stratton
    • Kannel WB, Sorlie P. Hypertension in Framingham. In: Paul O, ed. Epidemiology and Control of Hypertension. New York, NY: Thieme Stratton; 1975:553-592.
    • (1975) Epidemiology and Control of Hypertension , pp. 553-592
    • Kannel, W.B.1    Sorlie, P.2
  • 2
    • 0021354536 scopus 로고
    • Epidemiology of coronary heart disease: The Framingham study
    • Castelli WP. Epidemiology of coronary heart disease: the Framingham study. Am J Med. 1984;76:4-12.
    • (1984) Am J Med , vol.76 , pp. 4-12
    • Castelli, W.P.1
  • 3
    • 0024362676 scopus 로고
    • Blood pressure and risk of fatal coronary heart disease
    • Stamler J, Neaton JD, Wentworth DN. Blood pressure and risk of fatal coronary heart disease. Hypertension. 1989;13(suppl I):I-2-I-12.
    • (1989) Hypertension , vol.13 , Issue.1 SUPPL.
    • Stamler, J.1    Neaton, J.D.2    Wentworth, D.N.3
  • 4
    • 0025347391 scopus 로고
    • Blood pressure, stroke and coronary heart disease, II: Short-term reductions in blood pressure: Overview of randomized drug trials in their epidemiological context
    • MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J. Blood pressure, stroke and coronary heart disease, II: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. 1990;335:827-838.
    • (1990) Lancet , vol.335 , pp. 827-838
    • MacMahon, S.1    Peto, R.2    Cutler, J.3    Collins, R.4    Sorlie, P.5    Neaton, J.6    Abbott, R.7    Godwin, J.8    Dyer, A.9    Stamler, J.10
  • 5
    • 0021863832 scopus 로고
    • MRC trial of treatment of mild hypertension: Principal results
    • Medical Research Council Working Party. MRC trial of treatment of mild hypertension: principal results. BMJ. 1985;291:97-104.
    • (1985) BMJ , vol.291 , pp. 97-104
  • 7
    • 0027195457 scopus 로고
    • Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia and hyperinsulinemia
    • Lind L, Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia and hyperinsulinemia. Am Heart J. 1993(suppl);125:1494-1497.
    • (1993) Am Heart J , vol.125 , Issue.SUPPL. , pp. 1494-1497
    • Lind, L.1    Lithell, H.2
  • 8
    • 0031449649 scopus 로고    scopus 로고
    • Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
    • Lip GYH, Blann AD, Jones AF, Lin Lip P, Beevers DG. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol. 1997;80:1566-1571.
    • (1997) Am J Cardiol , vol.80 , pp. 1566-1571
    • Lip, G.Y.H.1    Blann, A.D.2    Jones, A.F.3    Lin Lip, P.4    Beevers, D.G.5
  • 9
    • 0027125530 scopus 로고
    • The pathogenesis of coronary artery disease and the acute coronary syndromes
    • Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 1992;326:242-250.
    • (1992) N Engl J Med , vol.326 , pp. 242-250
    • Fuster, V.1    Badimon, L.2    Badimon, J.J.3    Chesebro, J.H.4
  • 12
  • 13
    • 0027178119 scopus 로고
    • Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health Study
    • Lee AJ, Lowe GDO, Woodward M, Tunstall-Pedoe H. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J. 1993;69:336-342.
    • (1993) Br Heart J , vol.69 , pp. 336-342
    • Lee, A.J.1    Lowe, G.D.O.2    Woodward, M.3    Tunstall-Pedoe, H.4
  • 14
    • 0028909230 scopus 로고
    • Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
    • Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
    • (1995) N Engl J Med , vol.332 , pp. 635-641
    • Thompson, S.G.1    Kienast, J.2    Pyke, S.D.M.3    Haverkate, F.4    Van De Loo, J.C.W.5
  • 15
    • 0025948224 scopus 로고
    • Von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
    • Jansson JH, Nilsson TK, Johnson O. von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death. Br Heart J. 1991;66:551-555.
    • (1991) Br Heart J , vol.66 , pp. 551-555
    • Jansson, J.H.1    Nilsson, T.K.2    Johnson, O.3
  • 16
    • 0019490723 scopus 로고
    • Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: Role of fibrinogen and concentration
    • Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH. Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects: role of fibrinogen and concentration. Am J Med. 1981;70:1195-1202.
    • (1981) Am J Med , vol.70 , pp. 1195-1202
    • Letcher, R.L.1    Chien, S.2    Pickering, T.G.3    Sealey, J.E.4    Laragh, J.H.5
  • 17
    • 0027199192 scopus 로고
    • Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension
    • Linde T, Sandhagen B, Hagg A, Morlin C, Wikstrom, Danielson BG. Blood viscosity and peripheral vascular resistance in patients with untreated essential hypertension. J Hypertens. 1993;11:731-736.
    • (1993) J Hypertens , vol.11 , pp. 731-736
    • Linde, T.1    Sandhagen, B.2    Hagg, A.3    Morlin, C.4    Wikstrom5    Danielson, B.G.6
  • 18
    • 0025756530 scopus 로고
    • Association between plasma viscosity and blood pressure: Results from the MONICA-Project Augsburg
    • Koenig W, Sund M, Ernst E, Keil U, Rosenthal J, Hombach V. Association between plasma viscosity and blood pressure: results from the MONICA-Project Augsburg. Am J Hypertens. 1991;4:529-536.
    • (1991) Am J Hypertens , vol.4 , pp. 529-536
    • Koenig, W.1    Sund, M.2    Ernst, E.3    Keil, U.4    Rosenthal, J.5    Hombach, V.6
  • 19
    • 0026522735 scopus 로고
    • Rheological determinants of blood pressure in a Scottish adult population
    • Smith WCS, Lowe GDO, Lee AJ, Tunstall-Pedoe H. Rheological determinants of blood pressure in a Scottish adult population. J Hypertens. 1992;10:467-472.
    • (1992) J Hypertens , vol.10 , pp. 467-472
    • Smith, W.C.S.1    Lowe, G.D.O.2    Lee, A.J.3    Tunstall-Pedoe, H.4
  • 20
    • 0028094888 scopus 로고
    • Abnormalities of rheology and coagulation in hypertension
    • Lip GYH, Beevers DG. Abnormalities of rheology and coagulation in hypertension. J Hum Hypertens. 1994;8:693-702.
    • (1994) J Hum Hypertens , vol.8 , pp. 693-702
    • Lip, G.Y.H.1    Beevers, D.G.2
  • 23
    • 0027441963 scopus 로고
    • Fibrinolytic activity, clotting and long-term incidence of ischemic heart disease in the Northwick Park Heart Study
    • Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ. Fibrinolytic activity, clotting and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet. 1993;342:1076-1079.
    • (1993) Lancet , vol.342 , pp. 1076-1079
    • Meade, T.W.1    Ruddock, V.2    Stirling, Y.3    Chakrabarti, R.4    Miller, G.J.5
  • 24
    • 0027274074 scopus 로고
    • Endogenous tissue-type plasminogen activator and risk of myocardial infarction
    • Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993;341:1165-1168.
    • (1993) Lancet , vol.341 , pp. 1165-1168
    • Ridker, P.M.1    Vaughan, D.E.2    Stampfer, M.J.3    Manson, J.E.4    Hennekens, C.H.5
  • 25
    • 0027360661 scopus 로고
    • Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: A 7-year follow-up
    • Jansen J-H, Olofsson B-O, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease: a 7-year follow-up. Circulation. 1993;88: 2030-2034.
    • (1993) Circulation , vol.88 , pp. 2030-2034
    • Jansen, J.-H.1    Olofsson, B.-O.2    Nilsson, T.K.3
  • 26
    • 0031283158 scopus 로고    scopus 로고
    • The role of rheological and haemostatic factors in hypertension
    • Lee AJ. The role of rheological and haemostatic factors in hypertension. J Hum Hypertens. 1997;11:767-776.
    • (1997) J Hum Hypertens , vol.11 , pp. 767-776
    • Lee, A.J.1
  • 27
    • 0026064035 scopus 로고
    • Decreased fibrinolytic activity and increased platelet function in hypertension: Possible influence of calcium antagonism
    • Gleerup G, Winther K. Decreased fibrinolytic activity and increased platelet function in hypertension: possible influence of calcium antagonism. Am J Hypertens. 1991;4:168s-171s.
    • (1991) Am J Hypertens , vol.4
    • Gleerup, G.1    Winther, K.2
  • 29
    • 0028595706 scopus 로고
    • Fibrinolytic activity and platelet release reaction in essential hypertension
    • Keskin A, Tombuloglu M, Buyukkececi F. Fibrinolytic activity and platelet release reaction in essential hypertension. Jpn Heart J. 1994;35: 757-763.
    • (1994) Jpn Heart J , vol.35 , pp. 757-763
    • Keskin, A.1    Tombuloglu, M.2    Buyukkececi, F.3
  • 30
    • 0025234723 scopus 로고
    • Elevated fibrinogen and plasminogen activator inhibitor in hypertension are related to metabolic risk factors for cardiovascular disease
    • Landin K, Tengborn L, Smith U. Elevated fibrinogen and plasminogen activator inhibitor in hypertension are related to metabolic risk factors for cardiovascular disease. J Intern Med. 1990;227:273-278.
    • (1990) J Intern Med , vol.227 , pp. 273-278
    • Landin, K.1    Tengborn, L.2    Smith, U.3
  • 31
    • 0025922062 scopus 로고
    • Hypofibrinolysis in patients with hypertension and elevated cholesterol
    • Jansson JH, Johansson B, Boman K, Nilsson TK. Hypofibrinolysis in patients with hypertension and elevated cholesterol. J Intern Med. 1991; 229:309-316.
    • (1991) J Intern Med , vol.229 , pp. 309-316
    • Jansson, J.H.1    Johansson, B.2    Boman, K.3    Nilsson, T.K.4
  • 32
    • 0028355816 scopus 로고
    • Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: The Northern Sweden MONICA Study
    • Eliasson M, Evrin PE, Lundblad D. Fibrinogen and fibrinolytic variables in relation to anthropometry, lipids and blood pressure: the Northern Sweden MONICA Study. J Clin Epidemiol. 1994;47:513-524.
    • (1994) J Clin Epidemiol , vol.47 , pp. 513-524
    • Eliasson, M.1    Evrin, P.E.2    Lundblad, D.3
  • 33
    • 0027256179 scopus 로고
    • Von Willebrand factor and endothelial damage in essential hypertension
    • Blann AD, Naqvi T, Waite M, McCollum CN. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens. 1993;7: 107-111.
    • (1993) J Hum Hypertens , vol.7 , pp. 107-111
    • Blann, A.D.1    Naqvi, T.2    Waite, M.3    McCollum, C.N.4
  • 34
    • 0027417144 scopus 로고
    • Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients
    • Donders SHJ, Lustermans FATh, Van Wersch JWJ. Coagulation factors and lipid composition of the blood in treated and untreated hypertensive patients. Scand J Clin Lab Invest. 1993;53:179-186.
    • (1993) Scand J Clin Lab Invest , vol.53 , pp. 179-186
    • Donders, S.H.J.1    Lustermans, F.A.Th.2    Van Wersch, J.W.J.3
  • 35
    • 0028784671 scopus 로고
    • Enhanced levels of tissue-type plaminogen activator in borderline hypertension
    • Wall U, Jern C, Bergbrant A, Jem S. Enhanced levels of tissue-type plaminogen activator in borderline hypertension. Hypertension. 1995;26: 796-800.
    • (1995) Hypertension , vol.26 , pp. 796-800
    • Wall, U.1    Jern, C.2    Bergbrant, A.3    Jem, S.4
  • 36
    • 0029874352 scopus 로고    scopus 로고
    • The fibrinolytic system is not impaired in older men with hypertension
    • DeSouza CA, Dengel DR, Rogers MA, Cox K, Macko RF. The fibrinolytic system is not impaired in older men with hypertension. Hypertension. 1996;27:1053-1058.
    • (1996) Hypertension , vol.27 , pp. 1053-1058
    • DeSouza, C.A.1    Dengel, D.R.2    Rogers, M.A.3    Cox, K.4    Macko, R.F.5
  • 39
    • 0023840967 scopus 로고
    • Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay
    • Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood. 1988;71:220-225.
    • (1988) Blood , vol.71 , pp. 220-225
    • Declerck, P.J.1    Alessi, M.C.2    Verstreken, M.3    Kruithof, E.K.O.4    Juhan-Vague, I.5    Collen, D.6
  • 40
    • 0022894665 scopus 로고
    • Age dependence of tissue plasminogen activator concentrations in plasma, as studied by improved enzyme linked immunosorbent assay
    • Ranby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentrations in plasma, as studied by improved enzyme linked immunosorbent assay. Clin Chem. 1986;32:2160-2165.
    • (1986) Clin Chem , vol.32 , pp. 2160-2165
    • Ranby, M.1    Bergsdorf, N.2    Nilsson, T.3    Mellbring, G.4    Winblad, B.5    Bucht, G.6
  • 41
    • 33745551242 scopus 로고
    • Schnellmethode zur bestimmung des fibrinogens
    • Clauss A. Schnellmethode zur Bestimmung des fibrinogens. Acta Haematol. 1957;17:237-247.
    • (1957) Acta Haematol , vol.17 , pp. 237-247
    • Clauss, A.1
  • 42
    • 0025801764 scopus 로고
    • Correlation of circulation von Willebrand factor levels with cardiovascular hemodynamics
    • Penny W, Weinstem M, Salzman EW, Ware JA. Correlation of circulation von Willebrand factor levels with cardiovascular hemodynamics. Circulation. 1991;83:1630-1636.
    • (1991) Circulation , vol.83 , pp. 1630-1636
    • Penny, W.1    Weinstem, M.2    Salzman, E.W.3    Ware, J.A.4
  • 44
    • 0001519073 scopus 로고
    • The REG procedure
    • Cary, NC: SAS Institute Inc
    • SAS Institute Inc. The REG procedure. In: SAS/STAT User's Guide. Version 6. Vol 2. 4th ed. Cary, NC: SAS Institute Inc: 1989:1351-1456.
    • (1989) SAS/STAT User's Guide. Version 6. 4th Ed. , vol.2 , pp. 1351-1456
  • 45
    • 0030713021 scopus 로고    scopus 로고
    • The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure
    • Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The Sixth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
    • (1997) Arch Intern Med , vol.157 , pp. 2413-2446
  • 46
    • 0023484510 scopus 로고
    • Comparison of plasminogen activator inhibitor activity and antigen in plasma samples
    • Urden G, Hamsten A, Wiman B. Comparison of plasminogen activator inhibitor activity and antigen in plasma samples. Clin Chim Acta. 1987; 169:189-196.
    • (1987) Clin Chim Acta , vol.169 , pp. 189-196
    • Urden, G.1    Hamsten, A.2    Wiman, B.3
  • 47
    • 0026656288 scopus 로고
    • The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids
    • Marckmann P, Sandstrom B, Jepersen J. The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis. 1992;96:235-244.
    • (1992) Atherosclerosis , vol.96 , pp. 235-244
    • Marckmann, P.1    Sandstrom, B.2    Jepersen, J.3
  • 48
    • 0023144444 scopus 로고
    • Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: Correlation with age and serum triglyceride concentrations
    • Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol. 1987;9: 263-268.
    • (1987) J Am Coll Cardiol , vol.9 , pp. 263-268
    • Mehta, J.1    Mehta, P.2    Lawson, D.3    Saldeen, T.4
  • 49
    • 0025251843 scopus 로고
    • Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein
    • Stiko-Rahm A, Wiman B, Hamsten A, Nilsson J. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein. Arteriosclerosis. 1990; 10:1067-1073.
    • (1990) Arteriosclerosis , vol.10 , pp. 1067-1073
    • Stiko-Rahm, A.1    Wiman, B.2    Hamsten, A.3    Nilsson, J.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.